Novartis India Q1 FY27 Results (NSE: NOVARTIND)
Signal: Margin expansion
The read
Q1FY27 standalone results show strong double-digit revenue growth (+18.6% YoY) and even stronger PAT growth (+16.6% YoY), supported by operating leverage from declining employee costs (-10.8% YoY) and well-controlled other expenses (+2.4% YoY). Gross margins held steady (~46.4%), and the company remains debt-free with negligible finance costs. The only minor drag is lower other income (-17.7% YoY). Earnings quality is clean — no exceptional items, no dilution, and PAT/EPS move in lockstep. The open-offer tendering narrative (negligible tenders reported in June 2026) does not affect operating performance.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹103.81 Cr | 18.57% | 14.64% |
| EBIT | ₹43.11 Cr | 16.14% | |
| Net profit | ₹32.21 Cr | 16.62% | |
| EPS | ₹13.05 | 16.62% | |
| EBIT margin | 41.57% |
P&L walk
Standalone-only filer — no consolidated statement. Revenue rose 18.6% YoY to ₹1,038.1mn, driven by higher stock-in-trade purchases (net ₹556.7mn, +19.1%) consistent with in-licensed model; gross margin (revenue less net purchases) as % of revenue improved to 46.4% vs 46.2% a year ago (stable, ~20bps expansion). Employee costs declined 10.8% YoY as a % of revenue (4.5% vs 6.0%), providing operating leverage; other expenses rose just 2.4% YoY, well below revenue growth. EBITDA margin (PBT + finance cost + depreciation) at ~42.0% (implied EBITDA ₹435.9mn) expanded ~120bps YoY. PBT grew 16.0% despite lower other income (-17.7%). Tax rate 25.4% vs 25.8% YoY. PAT ₹322.1mn, +16.6% YoY; EPS ₹13.05 tracked PAT exactly. No segment data reported; pure domestic formulations.
Key positives
- Revenue grew 18.6% YoY to ₹1,038.1mn — accelerating from 3yr CAGR of -0.54%.
- Employee cost as % of revenue dropped from 6.0% to 4.5%, contributing to 120bps EBITDA margin expansion.
- Operating profit (PBT) grew 16.0% YoY despite lower other income.
- Debt-free balance sheet with finance cost of only ₹0.6mn.
Key concerns
- Other income declined 17.7% YoY, reducing total income growth to 14.7%.
- Current tax jumped 291.8% QoQ (though YoY +19.4% in line with profit growth).
- No segment or geographic revenue disclosure to assess growth drivers.
Research and educational content only. Not investment advice.